PELOAcademy | Engineering Cardiac Microtissues for Cell Replacement Therapy (Webinar | Online)
4. April 2024
Webinar
presented by Dr. Kurt Pfannkuche, Universität zu Köln Induced pluripotent stem cells (iPSCs) can be differentiated into heart muscle cells in vitro and open up new possibilities for the development of therapies for myocardial infarction. However, the transplantation of pure cardiac muscle cells from iPSCs has the disadvantage that only a small proportion of the cells remain in the tissue. The transplantation of micro-tissues containing other cardiac cell types in addition to cardiac muscle cells appears more promising. The productionWeiterlesen